Amy Griffin
Founding Partner & Managing Partner @ G9 Ventures
Amy Griffin is a Series A investor at G9 Ventures focused on Fitness and Wellness. Amy Griffin is the Founding Partner of G9 Ventures and Co-Founder of Social Studies. She attended University of Virginia.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Amy Griffin invests in
Stages Amy Griffin invests in
Countries Amy Griffin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Fitness 2 (50%)
- Wellness 2 (50%)
- Health Care 2 (50%)
- Beauty 1 (25%)
- Retail 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- United States 3 (75%)
- France 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| RŌZ provides individualized personal care products for skin and hair beauty, such as styling oil, treatment oil, repair, and style kits. | Seed / Aug 12, 2024 | ||
| Destree is a ready-to-wear and accessories label company. The company focuses on a Parisian design yet different style, drawing its beauty from the visual dissonances it evokes and which it translate through a graphic and structured aesthetic. Destree is a women's ready-to-wear and accessories brand created in Paris, France. | Series A / Apr 20, 2022 | ||
| AG1 (Athletic Greens) is a global health company with a mission to empower people to take ownership of their health through a focus on nutrition. The company's flagship product, AG1, is a research-backed daily health supplement that combines a high-quality multivitamin, probiotic, and more into a single scoop. AG1 is NSF Certified for Sport,one of the most rigorous independent quality and safety certification programs in the supplement industry, and a standard sought by many professional athletes, coaches, and trainers. Founded in 2010, AG1 has operations spanning North America, Europe, and Asia Pacific. | $115M / Venture - Series Unknown / Jan 25, 2022 | ||
| Zeera is a mental healthcare company that provides a digital platform and in-person experience for mental health patients. It made its mission to develop a new therapy model based on member-centered care that is affordable and effective. Zeera was founded in 2019 by Ariela Safira and is based in New York, United States. | $10M / Series A / Apr 06, 2021 |
Co-Investors
About G9 Ventures
G9 Ventures is investing in early-stage companies that empower the consumer to live, look, and feel better. The firm is headquartered in New York, United States.
G9 Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amy Griffin
Founding Partner & Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Amy Griffin invest in?
Amy Griffin invests primarily in Fitness, Wellness and Health Care startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amy Griffin?
Public channels for Amy Griffin include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Amy Griffin last invest?
The most recent investment recorded for Amy Griffin closed in Aug 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
